President Trump’s move to reclassify marijuana from a “Schedule I” to “Schedule III” drug stops short of full legalization.

The shift directed by President Trump — and President Biden before him — could also open the door to more research on the medical benefits of cannabis. But some observers also worry that implementation will come with significant challenges.

Numerous studies have concluded that regular use of cannabis brings serious health risks, as well as brain impairment among young people.

Florida’s attorney general is asking the state Supreme Court to review the constitutionality of an initiative to legalize marijuana that activists want to put on the 2026 ballot. The court accepted the request,

Trump is weighing a decision to move marijuana to Schedule III, which could ease taxes and expand medical access. Still, industry leaders warn it may also trigger stricter federal oversight and new legal risks.

Trump told reporters Monday that he was considering signing an executive order that would make cannabis a Schedule III drug, changing its long-held Schedule I status.

President Donald Trump is expected to address the potential loosening of federal regulations on marijuana on Thursday, according to a White House official, setting up a decision that could sharply reverse decades of U.

A group in Massachusetts is close to securing enough signatures to put an initiative on the November 2026 ballot to reverse the 2016 legalization decision. We’ll find out if they were successful this?